Huhn, O., O. Chazara, M. A. Ivarsson, C. Retière, T. C. Venkatesan, P. J. Norman, H. G. Hilton, J. Jayaraman, J. A. Traherne, J. Trowsdale, M. Ito, C. Kling, P. Parham, H. Ghadially, A. Moffett, A. M. Sharkey, and F. Colucci. 2018. High-resolution genetic and phenotypic analysis of KIR2DL1 alleles and their association with pre-eclampsia. J. Immunol. 201: 2593–2601.
The authors revised the grant footnote to include additional funding information. The corrected footnote is shown below:
This work was supported by the Wellcome Trust (Grant 200841/Z/16/Z to F.C. and A.M.), the Medical Research Council (Grant MR/P001092/1 to A.M.S.), the National Institutes of Health (Grants U01 AI090905 to P.J.N. and R01 AI17892 to P.P.), and the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre (BRC) Cell Phenotyping Hub (to F.C.). The Pregnancy Outcome Prediction Study is funded by the Women’s Health theme of the NIHR Cambridge BRC and the Stillbirth and Neonatal Death Society. O.H. was supported by a MedImmune-Cambridge Ph.D. fellowship. O.C. was supported by a Centre for Trophoblast Research Next Generation fellowship. M.A.I. was funded by the Wenner-Gren Foundations, Stockholm, Sweden. The project has received funding from the European Research Council under the European Union's Horizon 2020 research and innovation program (Grant Agreement 695551).
